Core Viewpoint - The Hong Kong IPO market is experiencing a surge in activity, highlighted by the successful listing of Lens Technology, which raised HKD 54.83 billion, marking it as the largest IPO project by CITIC Securities in Hong Kong for 2025 [1] Group 1: IPO Market Dynamics - The IPO market in Hong Kong is driven by the trend of A-share companies listing in Hong Kong, contributing to a total financing scale of HKD 880 billion in the first half of the year, reclaiming the top position globally [1] - On July 9, multiple companies, including Lens Technology, listed on the Hong Kong Stock Exchange, indicating a vibrant market with significant investor interest [1] - The listing of Lens Technology is part of a broader trend where major A-share companies are seeking dual listings to enhance their financing capabilities and global influence [2][5] Group 2: Lens Technology's Listing Highlights - Lens Technology's IPO is notable for being the first independent sponsorship project in Hong Kong with a market value exceeding HKD 100 billion in nearly two decades [1] - The company achieved a rapid listing process, completing the necessary steps in just 100 days [1] - The financing raised will primarily be used to strengthen Lens Technology's overseas business presence, particularly in Southeast Asia and North America [5][6] Group 3: Industry Trends and Future Outlook - The trend of A-share companies pursuing dual listings in Hong Kong is expected to continue, with many companies recognizing the advantages of accessing international capital markets [8][10] - The phenomenon of higher valuations in Hong Kong compared to A-shares is attributed to increased foreign investment and improved liquidity in the Hong Kong market [11] - There are currently 180 A-share companies in line for H-share listings, indicating a robust pipeline and a shift in asset pricing power towards Hong Kong [12][13]

芯碁微装最终募集资金净额比原计划少5708.17万元。芯碁微装2021年3月29日披露的招股说明书显示， 公司拟募集资金4.73亿元，其中，2.08亿元用于高端PCB激光直接成像（LDI）设备升级迭代项目， 9380.00万元用于晶圆级封装（WLP）直写光刻设备产业化项目，1.08亿元用于平板显示（FPD）光刻设 备研发项目，6355.00万元用于微纳制造技术研发中心建设项目。 待确定具体方案后，公司将根据相关法律法规，履行相关决策程序。本次H股上市事项尚需提交公司董 事会和股东大会审议，并需取得中国证券监督管理委员会、香港联交所和香港证券及期货事务监察委员 会等相关政府机关、监管机构备案、批准或核准。本次H股上市能否通过审议、备案和审核程序并最终 实施具有较大不确定性。公司将依据相关法律法规的规定，根据本次H股上市的后续进展情况及时履行 信息披露义务，敬请广大投资者注意投资风险。 2021年4月1日，芯碁微装在上交所科创板上市，发行数量为3020.24万股，发行价格为15.23元/股，保荐 机构为海通证券股份有限公司（现名"国泰海通证券股份有限公司"），保荐代表人为于军杰、林剑辉。 芯碁微装募集资金总额为4 ...

Core Viewpoint - Fengfan Technology (688279.SH) is set to become a dual-listed chip design company on both A-shares and H-shares, with recent stock price fluctuations reflecting market sentiment and the company's upcoming capital expansion plans [1]. Company Overview - Fengfan Technology specializes in the design and research of BLDC motor drive control chips, holding a 4.8% market share in China's BLDC motor control and drive chip market, ranking sixth overall and being the only Chinese company among the top ten [2][5]. - The company has a comprehensive product matrix covering core components of motor drive control systems, including MCU, ASIC, HVIC, and MOSFET [5]. Financial Performance - Revenue is projected to grow from 322.973 million RMB in 2022 to 600.325 million RMB in 2024, with a compound annual growth rate (CAGR) of 36.4% [7][8]. - Net profit is expected to increase from 142 million RMB in 2022 to 222 million RMB in 2024, with a CAGR of 25.1% [7][8]. Market Dynamics - The global and Chinese BLDC motor market is experiencing significant growth, with projected CAGRs of 22.6% and 24.9% from 2019 to 2023, respectively [11]. - The company faces intense competition from international firms, which hold 54.1% of the market share, prompting Fengfan Technology to adopt a "price-for-volume" strategy to expand its customer base [12]. Research and Development - High R&D investment is a key driver of the company's growth, with R&D expenses increasing from 64 million RMB in 2022 to 116.73 million RMB in 2024, representing 19.4%-20.6% of revenue [11]. - The company has accumulated 110 patents, including 68 invention patents, focusing on core algorithms and chip design [11]. Sales Strategy - The company has seen a rise in sales and distribution expenses, from 12.605 million RMB in 2022 to 24.670 million RMB in 2024, reflecting efforts to optimize customer structure and expand into new markets [12][13]. - The concentration of revenue from the top five customers has decreased from 56.6% in 2022 to 46.8% in 2024, indicating progress in diversifying its customer base [13]. Future Outlook - Fengfan Technology's growth potential is supported by the high demand in the BLDC motor drive control chip sector and its innovative product offerings, as it prepares for A+H share capital expansion [14]. - The company must balance pricing strategies and expenditure to optimize profitability while navigating potential risks related to customer concentration and R&D investment returns [14].

证券代码：600754/900934 证券简称：锦江酒店/锦江B股 公告编号：2025-029 上海锦江国际酒店股份有限公司 第十届董事会第四十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海锦江国际酒店股份有限公司（以下简称"公司"）于 2025 年 6 月 13 日 以电话、电子邮件和书面形式发出会议通知，2025 年 6 月 20 日以通讯方式召开第 十届董事会第四十二次会议，会议应参加表决董事 9 名，实际参加表决董事 9 名。 会议审议并通过了如下决议： 一、关于下属子公司股权出让事项签署意向书暨关联交易的议案 详见公司《关于下属子公司股权出让事项签署意向书暨关联交易的公告》（公 告编号：2025-029 号）。 本议案已经公司独立董事专门会议审议通过。 鉴于拟于境外发行股份（H 股）并在香港联合交易所有限公司（以下简称"香 港联交所"）上市（以下简称"本次 H 股上市"），为进一步完善公司治理结构， 符合境内外有关法律法规的规定以及相关监管要求，结合公司的实际情况及需求， 经董事会研究决定，同 ...

蓝鲨导读：开启国际化征程 作者 | 杨硕 编辑 | 卢旭成 6月19日，海天味业二次上市登陆港交所，募资总额超百亿港元，成为2025年港股消费领域规模最大的IPO项目。 上市首日，海天味业开盘价为37.5港元，较发行价（36.3港元）上涨3.3%。截至当日收盘，海天味业股价为36.6港元，市值2137亿港元（约合1957亿 元），大约为A股（2151亿元）市值的90%。 作为A股中鼎鼎有名的"酱油茅"，海天味业已登陆A股10年，巅峰时期市值近7000亿元，但随后由于种种因素，公司遭遇业绩、股价"双杀"。目前，海天 味业的市值较巅峰时期跌去超过60%。 值得一提的是，前不久（5月30日），海天味业还被调出上证50指数，其核心原因是市值排名下滑至第50名以外,叠加流动性指标不足,触发指数"优胜劣 汰"的调整规则。 二次上市登陆港股后，海天味业能够获得市场认可吗？ A+H股上市潮 今年以来，港股IPO市场持续活跃，宁德时代、恒瑞医药等A股上市公司已在港股上市，"A+H"上市模式持续升温。 消费企业在港股的表现也十分不俗：蜜雪集团、布鲁可、沪上阿姨上市首日涨幅均超40%，今年以来港股IPO募资金额最多的宁德时代上市首 ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不會就本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 本公告不會直接或間接於或向美國（包括美國的領土及屬地、美國任何州以及哥倫比亞特區）發 佈、刊發或派發。本公告並不構成亦不屬於在美國境內或於任何其他司法管轄區購買或認購發 售股份的任何要約或招攬的一部分。本公告所述發售股份並無亦不會根據《1933年美國證券法》 （經不時修訂）（「美國證券法」）或美國任何州或其他司法管轄區的證券法登記。發售股份不得 在美國境內提呈發售、出售、質押或以其他方式轉讓，惟獲豁免遵守美國證券法及《美國1940 年投資公司法》（「美國投資公司法」）登記規定及符合任何適用的州證券法則另作別論。發售股 份：(1)僅根據美國證券法第144A條或美國證券法或任何適用的州證券法的其他可用登記豁免 規定向合資格機構買家（定義見美國證券法第144A條）及合資格買家（定義見美國投資公司法第 2(a)(51)條）提呈發售及出售；及(2)於美國境外向非 ...

| | ■ 海天味业 分时 v 1天:1分K v □v □ △ 2 FID ■ | | 报价 | 分析 | 资讯 · | | 评论 · | | --- | --- | --- | --- | --- | --- | --- | --- | | | =+ 8 × ▽ ▽ × × ▽ × × × × × × Aa □ × ○ ○ | | 03288 海天味业 | | | | (0) | | | | 7 9 0 | | 38 000 ↑ +1.700 +4.68% 暗盘交易中 06/18 16:31 | | | | | 40.037 | | 10.30% | | | | | | | 39.804 | | 9.65% | ☆ 12 日 ♥ 自选 | | | | 微能交易 | | 39.570 | | 9.01% | 最高价 40.950 | 开盘价 39.950 | | 成交量 552.52万 | | | | | | 最低价 38.000 | 昨收价 36.300 | | 成交额 2.17亿 | | | 39.337 | | 8.37% | 平均价 39.339 | | 市盈率TIM 32.06 | 总市值 2215 ...

证券代码：300773 证券简称：拉卡拉 公告编号：2025-033 拉卡拉支付股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、股票交易异常波动情况 处于筹划阶段的重大事项。 不存在买卖公司股票的行为。 三、是否存在应披露而未披露信息的说明 本公司董事会确认，本公司目前没有任何根据《深圳证券交易所创业板股票 上市规则》等有关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、 意向、协议等；董事会也未获悉本公司有根据《深圳证券交易所创业板股票上市 规则》等有关规定应予以披露而未披露的、对本公司股票及其衍生品种交易价格 产生较大影响的信息；公司前期披露的信息不存在需要更正、补充之处。 四、风险提示 拉卡拉支付股份有限公司（以下简称"公司"）股票于2025年6月13日、 券交易所相关规定，属于股票交易异常波动的情况。 二、公司关注并核实情况 针对公司股票交易异常波动情况，公司董事会通过电话、网络通讯等问询 方式，对公司第一大股东、公司全体董事、监事及高级管理人员就相关问题进 行了核实，现将相关情况说明如下： 变化。 司上 ...

智通财经6月17日电，拉卡拉(300773.SZ)发布异动公告，公司经过自查，不存在违反公平信息披露的情 形。公司正在与相关中介机构就本次H股上市的具体推进工作进行商讨，待具体方案确定后，本次H股 上市工作尚需提交公司董事会和股东大会审议，并经中国人民银行批准、中国证券监督管理委员会备案 和香港联交所等监管机构审核。本次H股上市能否通过审议、备案和审核程序并最终实施具有较大不确 定性，敬请投资者注意投资风险。 拉卡拉：本次H股上市能否通过审议、备案和审核程序并最终实施具有较大不确定性 ...

Group 1 - The company announced plans to initiate the process for issuing H-shares and listing on the Hong Kong Stock Exchange to enhance its international presence and brand recognition [1] - The board of directors has authorized the management to start preparatory work for the H-share listing, with a timeframe of 12 months from the board's approval [1] - The H-share listing is subject to further approval from the board, shareholders, and relevant regulatory bodies including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [1] Group 2 - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 15, 2019, with an issuance of 83.47 million shares at a price of 18.26 yuan per share [2] - The total funds raised from the initial public offering amounted to 152.42 million yuan, with a net amount of 145.02 million yuan after deducting issuance costs [2] - The funds raised were intended for various projects including the production line for inorganic ceramic nanofiltration membranes and a research center for membrane materials and technology [2][3]